Eli Lilly and Company
PD-1 agonist antibodies and uses thereof
Last updated:
Abstract:
The present invention relates to anti-human PD-1 agonist antibodies, and uses thereof for treating autoimmune disorders such as rheumatoid arthritis or for decreasing rejection of transplanted cells and/or tissues.
Status:
Grant
Type:
Utility
Filling date:
22 Feb 2019
Issue date:
3 Dec 2019